Inozyme Pharma, Inc. (INZY)

Inozyme Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	24.58	34.59	32.92	23.32	28.04	31.61
Short-Term Investments	107.03	154	94.95	88.49	119.66	15.53
Cash & Short-Term Investments	131.61	188.59	127.87	111.8	147.7	47.13
Cash Growth	-31.61%	47.49%	14.37%	-24.30%	213.37%	9.20%
Other Receivables	-	0.39	0.12	0.06	0.16	0.1
Receivables	-	0.39	0.12	0.06	0.16	0.1
Prepaid Expenses	9.33	7.28	3.41	3.48	3.13	0.22
Total Current Assets	140.94	196.25	131.39	115.34	150.98	47.46
Property, Plant & Equipment	1.66	2.59	3.64	4.44	2.65	0.3
Long-Term Investments	-	-	-	-	12.2	-
Long-Term Deferred Charges	-	-	-	-	-	0.06
Other Long-Term Assets	0.77	2.01	4.16	3.76	3.54	0.13
Total Assets	143.36	200.85	139.2	123.54	169.36	47.94
Accounts Payable	2.21	1.17	2.54	2.39	3.07	0.9
Accrued Expenses	11.57	12.61	11.36	8.51	6.63	2.34
Current Portion of Leases	0.99	0.91	0.82	0.73	-	-
Other Current Liabilities	-	-	-	-	0.28	-
Total Current Liabilities	18.34	14.69	14.72	11.63	9.97	3.24
Long-Term Debt	42.07	44.77	4.14	-	-	-
Long-Term Leases	0.16	0.91	1.82	2.64	-	-
Other Long-Term Liabilities	-	-	0.12	-	1.29	-
Total Liabilities	60.57	60.37	20.8	14.27	11.26	3.24
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-In Capital	443.48	426.36	333.36	256.95	249.18	1.43
Retained Earnings	-360.88	-285.93	-214.76	-147.7	-91.08	-34.65
Comprehensive Income & Other	0.19	0.04	-0.21	0.02	0	0.01
Total Common Equity	82.79	140.48	118.39	109.27	158.1	-33.22
Shareholders' Equity	82.79	140.48	118.39	109.27	158.1	44.71
Total Liabilities & Equity	143.36	200.85	139.2	123.54	169.36	47.94
Total Debt	46.79	46.59	6.78	3.37	-	-
Net Cash (Debt)	84.82	142	121.09	108.43	147.7	47.13
Net Cash Growth	-46.43%	17.27%	11.67%	-26.59%	213.37%	9.20%
Net Cash Per Share	1.36	2.74	3.21	4.60	13.38	39.84
Filing Date Shares Outstanding	64.24	61.77	43.72	23.67	23.46	1.36
Total Common Shares Outstanding	64.18	61.77	40.39	23.67	23.38	1.2
Working Capital	122.59	181.56	116.68	103.71	141.01	44.22
Book Value Per Share	1.29	2.27	2.93	4.62	6.76	-27.58
Tangible Book Value	82.79	140.48	118.39	109.27	158.1	-33.22
Tangible Book Value Per Share	1.29	2.27	2.93	4.62	6.76	-27.58
Machinery	-	1.72	1.62	1.29	0.88	0.36
Leasehold Improvements	-	2.16	2.13	2.1	2.1	0.05

Source: S&P Capital IQ. Standard template. Financial Sources.